日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating CD16-Positive Monocyte-like Myeloid-Derived Suppressor Cells and Intermediate Monocytes Associated with Clinical and Immunological Complications in Pars Planitis Patients

循环中CD16阳性单核细胞样髓系来源抑制细胞和中间单核细胞与扁桃体周边部炎患者的临床和免疫并发症相关

Kosmaczewska, Agata; Przeździecka-Dołyk, Joanna; Ciszak, Lidia; Rojek-Gajda, Zofia; Frydecka, Irena; Turno-Kręcicka, Anna; Misiuk-Hojło, Marta; Pawlak, Edyta

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy

miR-155-5p沉默不改变CLL T细胞中BTLA分子的表达:对靶向免疫治疗的启示

Kosmaczewska, Agata; Ciszak, Lidia; Andrzejczak, Anna; Tomkiewicz, Anna; Partyka, Anna; Rojek-Gajda, Zofia; Frydecka, Irena; Wołowiec, Dariusz; Wróbel, Tomasz; Bojarska-Junak, Agnieszka; Roliński, Jacek; Karabon, Lidia

Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27(Kip1) and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia.

CDKN1B 和 CCND2 位点的遗传变异与 p27(Kip1) 和细胞周期调节因子 Cyclin D2 的关联性及慢性淋巴细胞白血病的易感性和临床病程

Ciszak Lidia, Kosmaczewska Agata, Pawlak Edyta, Frydecka Irena, Szteblich Aleksandra, Wołowiec Dariusz

Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors

骨髓瘤患者 PD-1 和 CTLA-4 检查点的异常表达在诊断时更为明显:对进展时间和治疗性检查点抑制剂反应的影响

Anna Kulikowska de Nałęcz, Lidia Ciszak, Lidia Usnarska-Zubkiewicz, Edyta Pawlak, Irena Frydecka, Magdalena Szmyrka, Agata Kosmaczewska

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production

慢性淋巴细胞白血病 (CLL) 中 BTLA 的表达:表观遗传调控及其对 CLL B 细胞增殖和 IL-4 产生能力的影响

Karabon, Lidia; Andrzejczak, Anna; Ciszak, Lidia; Tomkiewicz, Anna; Szteblich, Aleksandra; Bojarska-Junak, Agnieszka; Roliński, Jacek; Wołowiec, Dariusz; Wróbel, Tomasz; Kosmaczewska, Agata

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients

循环 CD4 T 细胞上免疫检查点的失调表达可能会使多发性骨髓瘤患者的临床结果和对检查点抑制剂治疗的反应变得复杂

Anna Kulikowska de Nałęcz, Lidia Ciszak, Lidia Usnarska-Zubkiewicz, Irena Frydecka, Edyta Pawlak, Magdalena Szmyrka, Agata Kosmaczewska

Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression

类风湿性关节炎患者外周血CD4+ T细胞的激活和抑制潜能的改变与疾病进展相关。

Kosmaczewska, Agata; Ciszak, Lidia; Swierkot, Jerzy; Szteblich, Aleksandra; Wiland, Piotr; Frydecka, Irena

Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression

晚期宫颈癌患者外周血T细胞中共刺激分子CD28和抑制分子CTLA-4表达失调提示存在与疾病进展相关的全身性免疫抑制。

Kosmaczewska, Agata; Bocko, Dorota; Ciszak, Lidia; Wlodarska-Polinska, Iwona; Kornafel, Jan; Szteblich, Aleksandra; Masternak, Anna; Frydecka, Irena